JPS6153267A - 酸化および湿気に抵抗性のプロカテロ−ル誘導体およびその製法 - Google Patents

酸化および湿気に抵抗性のプロカテロ−ル誘導体およびその製法

Info

Publication number
JPS6153267A
JPS6153267A JP60150329A JP15032985A JPS6153267A JP S6153267 A JPS6153267 A JP S6153267A JP 60150329 A JP60150329 A JP 60150329A JP 15032985 A JP15032985 A JP 15032985A JP S6153267 A JPS6153267 A JP S6153267A
Authority
JP
Japan
Prior art keywords
procaterol
derivative
carbon atoms
moisture
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60150329A
Other languages
English (en)
Japanese (ja)
Inventor
アイザツク・ゲイバー‐セラシー
ラツセル・ユー・ネスビツト・ジユニア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of JPS6153267A publication Critical patent/JPS6153267A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP60150329A 1984-08-17 1985-07-10 酸化および湿気に抵抗性のプロカテロ−ル誘導体およびその製法 Pending JPS6153267A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US641631 1984-08-17
US06/641,631 US4616022A (en) 1984-08-17 1984-08-17 Procaterol stabilization

Publications (1)

Publication Number Publication Date
JPS6153267A true JPS6153267A (ja) 1986-03-17

Family

ID=24573198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60150329A Pending JPS6153267A (ja) 1984-08-17 1985-07-10 酸化および湿気に抵抗性のプロカテロ−ル誘導体およびその製法

Country Status (14)

Country Link
US (1) US4616022A (en, 2012)
EP (1) EP0171969A3 (en, 2012)
JP (1) JPS6153267A (en, 2012)
KR (1) KR900001175B1 (en, 2012)
AU (1) AU572306B2 (en, 2012)
CA (1) CA1265142A (en, 2012)
DK (1) DK275885A (en, 2012)
ES (1) ES8701164A1 (en, 2012)
FI (1) FI852431A7 (en, 2012)
GR (1) GR851649B (en, 2012)
NZ (1) NZ212531A (en, 2012)
PH (1) PH20805A (en, 2012)
PT (1) PT80952B (en, 2012)
ZA (1) ZA854636B (en, 2012)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
US4687776A (en) * 1986-10-24 1987-08-18 Warner-Lambert Company Drug stabilization
WO1988007036A1 (en) * 1987-03-16 1988-09-22 University Of Florida LABILE KETONE DERIVATIVES OF 3-SUBSTITUTED-1-ALKYLAMINO-2-PROPANOLS AND THEIR USE AS beta-ADRENERGIC BLOCKERS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1108320A (en) * 1965-10-07 1968-04-03 Shionogi & Co Improvements in or relating to anti-microbial compositions
FR5129M (fr) * 1966-01-18 1967-06-05 Olivier Paul Gaudin Medicaments a base d'alkylsulfate d'homomyrtenyloxy-2 diethylamino-1 ethane
US4026897A (en) * 1974-01-31 1977-05-31 Otsuka Pharmaceutical Company 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives
BE896423A (fr) * 1983-04-11 1983-08-01 Ct Europ De Rech S Therapeutiq Nouveaux sels liposolubles de doxycycline et leur preparation

Also Published As

Publication number Publication date
KR860001790A (ko) 1986-03-22
PT80952B (pt) 1987-11-11
AU4388185A (en) 1986-02-20
ES8701164A1 (es) 1986-11-16
ZA854636B (en) 1986-02-26
NZ212531A (en) 1988-02-12
FI852431L (fi) 1986-02-18
US4616022A (en) 1986-10-07
DK275885D0 (da) 1985-06-18
PT80952A (en) 1985-09-01
PH20805A (en) 1987-04-21
GR851649B (en, 2012) 1985-11-26
DK275885A (da) 1986-02-18
EP0171969A3 (en) 1987-11-04
ES544571A0 (es) 1986-11-16
FI852431A7 (fi) 1986-02-18
KR900001175B1 (ko) 1990-02-27
CA1265142A (en) 1990-01-30
EP0171969A2 (en) 1986-02-19
FI852431A0 (fi) 1985-06-19
AU572306B2 (en) 1988-05-05

Similar Documents

Publication Publication Date Title
CA1251734A (en) Stabilized injectable solutions of piroxicam
SK282549B6 (sk) Spôsob stabilizácie naloxonhydrochloridu
KR890006650A (ko) 테트라하이드로-푸로 및 -티에노［2,3-c］피리딘, 약제학적 제제로서의 이의 용도 및 이의 제조방법
KR890000470A (ko) 2,2-디메틸크로만-3-올 유도체, 그의 제조방법 및 그를 함유하는 약학 조성물
KR880006193A (ko) 피페리딘 화합물 및 그의 제조 및 용도
KR910004599A (ko) 1,3-디하이드로-1-(피리디닐아미노)-2h-인돌-2-온, 이들의 제조방법 및 이들의 약제로서의 용도
JP2021519817A (ja) 液体薬学的製剤
CA1065251A (en) Antiviral agent
KR890005036A (ko) 아미드화합물, 이들의 제조방법 및 이들 화합물을 함유하여 위신경기능을 활성화하는 조성물
NO941036L (no) Sparfloxacinsalter og opplösninger inneholdende saltene
JPS6153267A (ja) 酸化および湿気に抵抗性のプロカテロ−ル誘導体およびその製法
JPS6030646B2 (ja) 皮膚処理組成物の安定化方法
US2407412A (en) Therapeutic solutions
EP0159777A1 (en) Stabilized 4-carbamoyl-imidazolium-5-olate
SK64399A3 (en) Multivalent salts of pyridostigmine and related compounds
KR950003493B1 (ko) 알카토닌 수용액조성물
JPS62265220A (ja) １，４−ジヒドロキシ−５，８−ビス〔２−（２−ヒドロキシエチルアミノ）−エチルアミノ〕アントラキノン二塩酸塩の安定な注射用医薬配合物
US4344950A (en) Parenteral solvent and a process for the preparation of stable solutions containing same
KR870006043A (ko) 피라진유도체 그 제조방법 및 약제조성물
ATE48130T1 (de) Alpha-aryl-alpha-pyridylalkanoicsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung.
ES384946A1 (es) Un procedimiento para la preparacion de un compuesto quimi-co seleccionado entre el grupo formado por una n-(1-adaman- til) urea.
Murata et al. Bioavailability and pharmacokinetics of an oral dopamine prodrug in dogs
WO1995020956A1 (en) Anti-tumour medical preparation on the basis of carboplatin and the method of its production
NZ505080A (en) Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid
US4742082A (en) Solution of luprostiol and 1,2,-propanediol and methods of preparation and use